HerbaSway introduces Last Round to cap off night
WALLINGFORD, Conn. HerbaSway has introduced a hangover support in a ready-to-drink single “shot.”
Last Round is a 2.5-oz. bottle that contains such ingredients as kudzu root, stevia and green tea extracts. Last Round works by removing the effects of alcohol, “relaxing” the flow of blood and oxygen to the brain, and detoxifying the body so users avoid headaches, dry mouth and other ailments associated with hangovers, the company said. HerbaSway also recommended drinking one 2.5-oz. bottle of Last Round just before bedtime.
“Our whole philosophy at HerbaSway revolves around living a natural lifestyle, and as a natural hangover support, Last Round fits perfectly alongside our other product lines,” said Robert Wolfson, president of HerbaSway. “Drinking moderately and responsibly also fits into our philosophy, but we recognize that there are times when people go a little overboard. On these occasions, a final shot of Last Round provides protection against hangovers the next day. As we say on the bottle, it’s the best way to end a night of drinking.”
Last Round is available online and at retail shops nationwide, including Whole Foods. It is sold in two-packs, six-packs, 12-packs and party packs of 50 bottles.
Cirrus targets ear-ringing with Tinnitex
COLD SPRING HARBOR, N.Y. Cirrus Healthcare Products has expanded its ear care offerings with a new product, slated to hit retail shelves in spring 2011.
Tinnitex is the first and only earplug to help relieve tinnitus, a condition that causes ringing in the ears, the company said. According to the Journal of Clinical Nursing, more than 50 million Americans suffer from tinnitus.
“Tinnitex gives the suffering consumer an option to the inconvenience of ear drops or the excessive amount of pills that consumers are tired of taking. The Tinnitex earplug is easy to apply and comfortable to wear and, at about $10 at retail for six pairs, provides affordable relief,” said Cirrus CEO Drew O’Connell.
GSK Consumer Healthcare to FDA: Smoke out smokeless tobacco products
PARSIPPANY, N.J. GlaxoSmithKline Consumer Healthcare is urging the Food and Drug Administration to remove smokeless tobacco products from the market.
GSK Consumer Healthcare, which manufactures such nicotine-replacement therapy products as Nicorette and NicoDerm CQ, submitted a comment to the FDA on the potential public health impact of oral dissolvable tobacco products, "calling for such products to be withdrawn from the market until their sponsors can demonstrate to [the FDA] that their marketing is appropriate for the protection of public health," the company noted in a release Tuesday.
The announcement comes after the American Heart Association issued a policy statement on smokeless tobacco products, which said that such products are not safe alternatives to smoking and are associated with heart attack, stroke and certain cancers.
GSK Consumer Healthcare also said that it is committed to working with the FDA, in addition to medical and clinical experts to make smoking-cessation products safe and available for consumers.